Key points
- CDC's Advanced Molecular Detection (AMD) program is helping build and integrate the use of genomic sequencing technologies into public health nationwide.
- The cumulative local investment to Virginia from FY2021-2023 is $21,163,855.
- Virginia serves the Mid-Atlantic region as the Bioinformatic Regional Resource Lead, AMD Training Lead, and Community of Practice Domain Lead.
- Virginia is the principal investigator for the Virginia Pathogen Genomics Center of Excellence.
![Virginia map of blue dots on white background Virginia map of blue dots on white background](/advanced-molecular-detection/images/investments/investment-va-dots.jpg)
Total investment: $21,163,855
- State and Local Investment: $14,163,855
- Centers of Excellence (FY2022-2023): $7,000,000
Funding to public health departments includes support from the American Rescue Plan Act of 2021 and AMD annual appropriations in FY2021-2023.
Implementing AMD technology
The AMD program builds and integrates laboratory, bioinformatics, and epidemiology technologies across CDC and nationwide. Since 2014, AMD has received support from Congress—now a $40 million per year appropriation—to implement these technologies in public health programs. Through investments in AMD technologies, CDC is improving both public health outcomes and preparedness in dozens of areas including foodborne disease, influenza, antibiotic resistance, hepatitis, pneumonia, and meningitis.
With funding from the American Rescue Plan Act of 2021, the AMD program developed a multi-year plan to expand support to state, local, and territorial public health laboratories providing more staff and resources to collect and sequence SARS-CoV-2 specimens, identify and track variants, and share data for public health use.
Workforce development
Virginia is part of the Mid-Atlantic region. In 2018, the AMD program established workforce development regions across the country. Each region has an AMD training lead and a bioinformatics lead. This provides a network of customized AMD support which helps develop skills and provides training assistance to public health labs across the country.
Virginia's Bioinformatic Regional Resource Lead acts as a regional consultant. They provide support to labs within the region on data analysis and how to interface with IT departments. Its AMD Training Lead provides support to labs in the Central region on pathogen-specific training and cross-cutting AMD training to help staff develop the critical skills necessary to extract, analyze, and interpret sequencing data.
AMD Platform Community of Practice (CoP)
The Office of AMD has established five communities of practice to build processes and tools for relevant interests, concerns, and priorities regarding the AMD Platform. The AMD Platform will serve CDC programs and STLT partners by providing a common infrastructure to perform genomic epidemiology and contribute high-quality data to publicly available data repositories. Virginia's Domain Leader facilitates collaboration between OAMD and the public health community for the Applied Genomic Epidemiology CoP.
US Pathogen Genomics Centers of Excellence (PGCoE) network
The US Pathogen Genomics Centers of Excellence (PGCoE) network will foster and improve innovation and technical capacity in the use of pathogen genomics, molecular epidemiology, and bioinformatics in the field of public health. The Virginia Pathogen Genomics Center of Excellence is led by the Virginia Division of Consolidated Laboratory Services, a division under the Virginia Department of General Services, in partnership with the Virginia Department of Health, Virginia Commonwealth University, and the University of Virginia.